Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 10Thoracic 4Gynecologic 3Sarcoma 1NET 1Head & Neck 1Endocrine 1Dermatologic 1Breast 1

Conditions

Melanoma 320Carcinoma, Non-Small-Cell Lung 73Skin Neoplasms 65Carcinoma, Renal Cell 48Breast Neoplasms 46Lung Neoplasms 45Colorectal Neoplasms 43Neoplasms 41Carcinoma, Basal Cell 41Neoplasm Metastasis 40Squamous Cell Carcinoma of Head and Neck 36Uveal Melanoma 34Ovarian Neoplasms 34Carcinoma, Merkel Cell 32Sarcoma 31Lymphoma, T-Cell, Cutaneous 31Pancreatic Neoplasms 26Prostatic Neoplasms 24Head and Neck Neoplasms 22Stomach Neoplasms 21Thyroid Neoplasms 20Carcinoma, Hepatocellular 20Urinary Bladder Neoplasms 19Uterine Cervical Neoplasms 18Esophageal Neoplasms 18Carcinoma, Squamous Cell 18Mycosis Fungoides 16Carcinoma, Transitional Cell 16Brain Neoplasms 16Recurrence 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intestinal Neoplasms × Dermatologic × 90 days × Clear all
NCT05379985 2026-05-15

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Revolution Medicines, Inc.

Phase 1/2 Recruiting
754 enrolled
DermatologicGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplastic Processes, Pancreatic Neoplasms, Thoracic Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡